论文部分内容阅读
目的:评价宫腔镜治疗肥胖患者子宫黏膜下肌瘤的疗效及其安全性。方法:经宫颈子宫肌瘤切除术或同时行经宫颈子宫内膜切除术者66例,黏膜下子宫肌瘤中0型32例,Ⅰ型26例,Ⅱ型8例。根据术后月经改善情况、剩余肌瘤有无增长、是否再次手术等将疗效分为满意和不满意。结果:应用宫腔镜手术治疗黏膜下子宫肌瘤,术后满意率为97%,0型、I型术后满意率达100%。Ⅱ型子宫肌瘤中切除范围≥70%者2例,术后随访残余肌瘤不再增长。全部手术无1例发生并发症。结论:宫腔镜是治疗肥胖患者黏膜下肌瘤的最佳方法。掌握肥胖患者的生理特点、充分做好围手术期评估、术前准备完善,可降低此类患者的宫腔镜手术及麻醉风险。
Objective: To evaluate the efficacy and safety of hysteroscopy in the treatment of uterine submucous myoma in obese patients. Methods: 66 cases of cervical hysteromyoma or simultaneous cervical endometrial ablation, 32 cases of type 0 in submucosal uterine fibroids, 26 cases of type Ⅰ and 8 cases of type Ⅱ. According to the improvement of postoperative menstruation, whether the remaining fibroids growth, whether the surgery again, etc. will be divided into satisfaction and dissatisfaction. Results: Hysteroscopic treatment of submucosal uterine fibroids, postoperative satisfaction rate was 97%, 0, I-type satisfaction rate of 100%. Type II uterine fibroids in the removal of ≥ 70% in 2 cases, follow-up residual fibroids no longer. No complications occurred in all cases. Conclusion: Hysteroscopy is the best method to treat submucosal fibroids in obese patients. To master the physiological characteristics of obese patients, fully perioperative assessment, improve preoperative preparation, can reduce such patients hysteroscopic surgery and anesthesia risk.